Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by eXoZymes Inc.

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ MDBH
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
From eXoZymes Inc.
Via GlobeNewswire
Tickers IZTC MDBH
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.